Legal Phen Alternative

Phentermine, also known as “Phen”. Probably the best weight loss pill. Utilized by a lot of celebrities and everyday people to shed unwanted weight and fat. Legal Phen alternative, safe without any of the bad side effects of Phentermine. Also, 100% legal and contains no banned substances.

XenaPhen- Legal Phen Alternative

History of Phentermine, “Fen Phen “, “Phen”

IN 1995, desperate for extra money, Dr. Israel Levavi, a Los Angeles internist, went to work for a brief period at a weight loss clinic, run by a chiropractor and overseen by an infectious disease specialist. Paid $50 an hour to race through what he called ”very, very cursory exams” of six new patients an hour. The patients paid the clinic $100 for an exam and paid an additional $27 for blood tests. The clinic’s weight loss education program, Dr. Levavi added, ”consisted of a video loop in the waiting room.” It was, he said, ”very upbeat, showing 350 pounds melting into 135.”

Dr. Levavi gave the patients what they wanted, prescriptions for the diet drugs known as fen-phen. Fen referring to fenfluramine or dexfenfluramine, an appetite depressant. Phen referring to phentermine, a type of amphetamine. When patients needed refills, the chiropractor would hand them prescriptions pre-signed by the infectious disease specialist who ran the clinic, Dr. Levavi said.

The Fall Of Fen Phen

On Sept. 15, fenfluramine and dexfenfluramine were withdrawn from the market by their makers, responding to a request by the Food and Drug Administration, because doctors had submitted new data to the agency indicating that the drugs may cause heart valve defects in as many as a third of patients. The rise and fall of the fen-phen craze is a morality tale for our times, said some medical experts. The drug combination, which seemed a magic pill for the national epidemic of obesity, soared to popularity on the basis of a single study involving just 121 patients. Eventually, an estimated six million Americans took fenfluramine or dexfenfluramine, most of them women, not all of them obese.

The tale speaks to the limitations of current methods of evaluating drug safety. It speaks to the willingness of some doctors, who see a quick flow of ready cash free from the constraints of managed care, to lure desperate patients, who will do almost anything to lose weight. It also raises questions about the Food and Drug Administration’s standards for approving diet drugs, as well as about the way that drugs are monitored after they are on the market.

Showing the single result